FDA Lends a Single Arm: Papzimeos Approval Highlights FDA’s Willingness to Rely on Single-Arm Trials for Rare Diseases By James E. Valentine & Sarah Wicks —

https://www.thefdalawblog.com/2025/09/fda-lends-a-single-arm-papzimeos-approval-highlights-fdas-willingness-to-rely-on-single-arm-trials-for-rare-diseases/?utm_source=rss&utm_medium=rss&utm_campaign=fda-lends-a-single-arm-papzimeos-approval-highlights-fdas-willingness-to-rely-on-single-arm-trials-for-rare-diseases